Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 41 of Ernexa Therapeutics Inc.'s SEC filings and found 5 warrant series, 4 convertibles, 1 ATM program, 1 equity line, 5 shelf registrations, 2 S-1 registrations and 2 completed offerings on file for ERNA. The latest dilution event on file is ATM sales on Aug 6, 2026. Analysis updated Nov 3, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
GRIGRI Bio, Inc.
KALAKALA BIO, Inc.
JUNSJupiter Neurosciences, Inc.
APVOAptevo Therapeutics Inc.
LIMNLiminatus Pharma, Inc. Class A Common Stock
PMCBPharmaCyte Biotech, Inc.
SXTP60 Degrees Pharmaceuticals, Inc.
DRMADermata Therapeutics, Inc.
CMNDClearmind Medicine Inc.
CVKDCadrenal Therapeutics, Inc. Common Stock
MDCXMedicus Pharma Ltd. Common Stock
REVBRevelation Biosciences, Inc.
BDRXBiodexa Pharmaceuticals plc American Depositary Shs
CODXCo-Diagnostics, Inc.
ONCOOnconetix, Inc.